Patents Assigned to XIZANG HAISCO PHARMACEUTICAL CO., LTD.
  • Patent number: 11964964
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with thyroid hormone receptor activity. The methods and compositions disclosed herein include the use of at least one thyroid hormone receptor agonist.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: April 23, 2024
    Assignee: XIZANG HAISCO PHARMACEUTICAL CO., LTD.
    Inventors: Bohan Jin, Gene Hung, Qing Dong
  • Publication number: 20240092768
    Abstract: Disclosed are a crystal form of a compound (1S,2S)-2-fluoro-N-(2-(2-(4-((R)-(5-methyl-2H-tetrazol-2-yl)(phenyl)methyl)piperidine-1-formyl)pyridin-4-yl)benzo[d]oxazol-5-yl)cyclopropyl-1-carboxamide having a structure of formula (A), a preparation method for the crystal form, and a use of the crystal form in the preparation of a drug for treating and/or preventing influenza.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 21, 2024
    Applicant: XIZANG HAISCO PHARMACEUTICAL CO., LTD.
    Inventors: Yao LI, Guobiao ZHANG, Xiaobo ZHANG